Targeted Therapy in Head and Neck Cancers 23rd April 2016; Update on Oral Cavity Cancers; Dr. B. Nanavati Hospital. Mumbai.
Oral Presentation- Pink Poll 2 at Mumbai. July 2009.
Oral Presentation- A Peculiar/rare case report of a Youngest Indian Patient of CLL with a Complex Karyotype. Adwaita Gore, Mamta Yargop, Tapan Saikia, V P Antia, Prochi Madon at Mumbai Hematology Group Mid Term Meeting November 2009. Conducted at Choksi Auditorium, Tata Memorial Hospital. Mumbai. Won Best Case Report prize.
Oral Presentation- Autologous Peripheral blood stem cell transplant data from a transplant center in Mumbai. Adwaita Gore, Ritu Jain, Nandini Hazarika, Boman Dhabhar, Sumaiya Matwankar, Shrusti Jadhav, Tapan Saikia at Mumbai Hematology Group Mid Term Meeting November 2009. Conducted at Choksi Auditorium, Tata Memorial Hospital. Mumbai.
Poster Presentation- Single-Dose Pegylated-Filgrastim Versus Daily Filgrastim After High-Dose Chemotherapy And Autologous Stem Cell Transplantation For Hematolymphoid Malignancies. Adwaita Gore, Amit Ghankar, Sumaiya Matwankar, Reetu Jain, Boman Dhabhar, Tapan Saikia at 37th Annual Conference of Mumbai Hematology Group 23rd March 2014. Conducted at ACTREC, Navi Mumbai.
Poster presentation- Unusual Cytogenetics in Hematological Malignancies at Mumbai Hematology Group Annual Conference, Mumbai 2008. Conducted by Mumbai Hematology Group.
Engraftment Syndrome Clinical features and predictive factors in Autologous Stem cell Transplant. Sheth V, Jain R, Gore A, Ghanekar A, Saikia T. Indian J Hematol Blood Transfus 2018 Jul;34(3):448-453.
Oncogenic drivers in non small cell lung cancer and resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Pathak A, Rajappa S, Gore A. Indian J Cancer 2017;54:S1-8.
Optimizing treatment in HR +ve Metastatic Breast Cancer. 13th October 2017.
Role of Chemotherapy in Newly diagnosed Carcinoma Prostate. 29th September 2017. IMA Juhu Annual Meeting. IMA Hall Juhu.
Management of Metastatic Carcinoma Prostate. 17th September 2017, Uro Oncology Meeting Chembur.
Changing paradigms in management of Prostate Cancer. 5th February 2017. Chembur IMA Update.
Speaker – 2nd YIR Conference in Breast Cancer 2017. 21- 22 January 2017 at Tata Medical Center, Mumbai.
Cancer Awareness talk 17 September 2016 at DNVG International, Peninsula Park, BKC Annexe. Kurla West.
Cancer Awareness talk 29th July 2016 at Vagad Samaj Ghatkopar West.
Conventional Docetaxel- Merits & Demerits and Indian study of vitamin E TPGS docetaxel & Experience: 21st May 2016. Sayre Therapeutics.
Suspecting and evaluating a possible Lung Cancer diagnosis 20th March 2016, Prince Aly Khan Hospital, PROMOTE INDIA Meeting.
LACE vs BEAM conditioning in relapse and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy. Int J Hematol. 2016 Mar; 103(3):292-8
Ruxolitinib in myelofibrosis and polycythemia vera - What is new ? 39th Annual Conference of Mumbai Hematology Group, 13th March 2016.
Locally Advanced NSCLC: Role of Chemotherapy : 20th February 2016; Lung Cancer Update; Hyatt Regency, Mumbai. Under aegis of AIO.
Managing Lung Carcinoma in 2016: First Annual Continuing Medical Education (CME) Programme on 14th February, 2016 at The Convention Centre, Tata Institute of Social Sciences, Deonar.
Year in Review : Breast Cancer Conference 2016: 16-17th Jan 2016 at Tata Memorial Hospital. Mumbai.
Gene Expression Profiling in Breast Cancer. 9th Jan 2016. Sofitel BKC. Mumbai.
Optimal Sequencing of targeted therapies in mCRC in second line and beyond. 21 Nov 2015; Mumbai Oncology Association Meeting.
Engraftment Syndrome following Hematopoietic stem cell transplant: A retrospective review of 70 cases. Adwaita Anant Gore, Vipul Sheth, Amit Ghanekar, Reetu Jain, Tapan K Saikia; Prince Aly Khan Hospital, Mumbai, India; Tata Memorial Centre, Mumbai, India; Prince Aly Khan Hospital. Aga Hall, Nesbit Road, Mazagaon, Mumbai, India. J Clin Oncol 33, 2015 (suppl; abstr e18010).
Efficacy of plerixafor with GCSF for mobilization of PBSC: A single center experience. Adwaita Anant Gore, Vipul Sheth, Amit Ghanekar, Reetu Jain, Tapan K Saikia; Prince Aly Khan Hospital, Mumbai, India; Tata Memorial Centre, Mumbai, India; Prince Aly Khan Hsopital. Aga Hall, Nesbit Road, Mazagaon, Mumbai, India. J Clin Oncol 33, 2015 (suppl; abstr e18011).
LONG TERM RESULTS OF AUTOLOGOUS TRANSPLANTS FOR LYMPHOMAS FROM INDIA: A RETROSPECTIVE MULTICENTER ANALYSIS. Oral Presentation at APBMT 2013.
Long Term Outcome Of Autologous Stem Cell Transplant In Multiple Myeloma From India A Retrospective Multicenteric Analysis. Reetu Ashish Jain MD Bhausaheb Bagal MD DM, Adwaita Gore¨MD Hari Menon MD, DM, Manju Sengar MD, DM, Sadhana Kannan MSc, Libin Mathew, Ganapathy Bhat MD, Amit Ghanekar MD, Navin Khattry MD, DM, Suresh Advani MD, Reena Nair MD and Tapan Saikia MD. Oral Presentation for ASH 2013.
Comparison of Toxicity and Outcomes of BCNU-Containing Conditioning Regimens Vs LACE in Lymphoma Transplants: A Retrospective Multicenter Analysis . ASH 2011 Poster Presentation. Navin Khattry, MD, DM1,2*, Reetu Jain, MD3*, Ravi Thippeswamy, MD2*, Adwaita Gore, DNB4*, Bharat Bhosale, MD2*, Nandish Jeevangi, MD, DM2*, Sadhana Kannan, MSc5*, Amit Joshi, MD, DM1,2*, Reena Nair, MD1 and Tapan Saikia, MD
Epithelial growth factor receptor (EGFR) expression in squamous cell cancer of buccal mucosa: Incidence and correlation with tumour characteristics in Indian population. A. A. Gore, P. Dwivedi, B. N. Dhabhar, T. K. Saikia; Prince Aly Khan Hospital, Mumbai, India; Department of Medical Oncology, Prince Aly Khan Hospital, Mumbai, India. J Clin Oncol 29: 2011 (suppl; abstr e16021).
Chemoradiation for Laryngeal Cancer: Present Scenario. Adwaita Gore, Pushkal Dwiwedi, Boman Dhabhar, Tapan K Saikia. Otorhinolaryngology Clinics: An International Journal, September-December 2010;2(3).
Immunecytopenia in Chronic Lymphocytic Leukemia. Adwaita Gore, Hem-Onc (India) Newsletter, Vol 2, June 2009, 38-40.
Emerging Therapies in Chronic Lymphocytic Leukemia. Adwaita Gore, Tapan Saikia. Hem-Onc (India) Newsletter, Vol 2, June 2009, 31-33.
CLINICAL TRIALS INVESTIGATOR
Principal Investigator & Co-Investigator- For Multiple National and International Clinical trials. Phase II and Phase III.